Factsheet – How the European Commission works on Rare Diseases and the European Reference Networks (ERNs)

Overview of the European Commission’s coordinated approach to rare diseases, including policy, research, and the role of European Reference Networks.

This factsheet outlines how the European Commission supports action on rare diseases through policy frameworks, research funding, and collaboration across Member States. It explains the role of European Reference Networks (ERNs) as cross-border networks connecting specialised centres to address rare and complex conditions, and highlights initiatives related to orphan medicines, medical devices, and data sharing, including the European Health Data Space.

Year of publication

2026

Source

European Commission – Directorate-General for Health and Food Safety

Author

Directorate-General for Health and Food Safety (European Commission)

You might also be interested in

This 2025 country report outlines the policy, research, care and support landscape for rare diseases in France.
December 4 @ 12:00 pm - 1:00 pm
Understanding the ethical concerns of AI in rare disease research and the principles of trustworthy AI
ERDERA’s third General Assembly brought partners together in Coimbra to review its second year, strengthen connections across the partnership and align priorities for a more integrated and delivery-focused third year.
ERDERA marked the close of its second year with an Open Session on ultra-rare diseases, bringing together European, regulatory and scientific perspectives on how innovation can reach patients.